Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic
|
By LabMedica International staff writers Posted on 08 Dec 2020 |

Illustration
The global viral RNA extraction kit market is projected to record significant growth in the years to come, driven by the ongoing COVID-19 pandemic as a number of biotech companies race against time to come up with a coronavirus vaccine.
These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.
Viral RNA extraction kits are intended for the purpose of separation of trace amounts of viral RNA from given samples, along with body fluids, plasma, serum, and blood. Additionally, the kits offer high quality outcome of viral Ribonucleic acid (RNA) for the purpose of downstream utilization in various applications, such as alternative PCR-based assays, microarrays, and RT-PCR. These kits are ready to use and are found in a wide variety of formats, such as multi-well, magnetic-based, and spin column for the purpose of better and higher output abilities. Few of the kits also offer synchronal assortment of Deoxyribonucleic acid (DNA).
Increased research and development activities, greater mechanization, and considerable technological progress made in the process of extraction is likely to propel growth of the global viral RNA extraction kit market in the years to come. Additionally, there has been increased demand for various user-friendly products, which is likely to augur well for the market. A surge in cases of various diseases, such as genetic disorders, cancer, dermatological diseases, and infectious diseases, has resulted in increased demand for extraction of viral RNA process in the field of molecular diagnostics. However, significantly low level penetration of products and a dearth of awareness among people in the under-developed markets is likely to limit the growth of the global viral RNA extraction kit market in the years to come. Geographically, the global viral RNA extraction kit market is likely to be dominated by the North America region. Increased government support, technological advancements, and significant R&D in pharmaceutical and biotechnology firms are likely to emerge as important factors for the growth of the North American viral RNA extraction kit market in the near future.
Related Links:
Transparency Market Research
These are the latest findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.
Viral RNA extraction kits are intended for the purpose of separation of trace amounts of viral RNA from given samples, along with body fluids, plasma, serum, and blood. Additionally, the kits offer high quality outcome of viral Ribonucleic acid (RNA) for the purpose of downstream utilization in various applications, such as alternative PCR-based assays, microarrays, and RT-PCR. These kits are ready to use and are found in a wide variety of formats, such as multi-well, magnetic-based, and spin column for the purpose of better and higher output abilities. Few of the kits also offer synchronal assortment of Deoxyribonucleic acid (DNA).
Increased research and development activities, greater mechanization, and considerable technological progress made in the process of extraction is likely to propel growth of the global viral RNA extraction kit market in the years to come. Additionally, there has been increased demand for various user-friendly products, which is likely to augur well for the market. A surge in cases of various diseases, such as genetic disorders, cancer, dermatological diseases, and infectious diseases, has resulted in increased demand for extraction of viral RNA process in the field of molecular diagnostics. However, significantly low level penetration of products and a dearth of awareness among people in the under-developed markets is likely to limit the growth of the global viral RNA extraction kit market in the years to come. Geographically, the global viral RNA extraction kit market is likely to be dominated by the North America region. Increased government support, technological advancements, and significant R&D in pharmaceutical and biotechnology firms are likely to emerge as important factors for the growth of the North American viral RNA extraction kit market in the near future.
Related Links:
Transparency Market Research
Latest Industry News
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
- GSI Group Acquires Blood Processing Equipment Manufacturer GenesisBPS
- ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases
- Lumiquick Acquires Aoxre to Expand Global IVD and Research Capabilities
- Lunit and Agilent Partner to Develop AI-Powered Cancer Diagnostics
- Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








